183 related articles for article (PubMed ID: 30993584)
1. Special Considerations in the Treatment of Mycosis Fungoides.
Duffy R; Jennings T; Kartan S; Song A; Shi W; Porcu P; Alpdogan O; Sahu J
Am J Clin Dermatol; 2019 Aug; 20(4):571-578. PubMed ID: 30993584
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
3. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides.
Saleh MN; LeMaistre CF; Kuzel TM; Foss F; Platanias LC; Schwartz G; Ratain M; Rook A; Freytes CO; Craig F; Reuben J; Sams MW; Nichols JC
J Am Acad Dermatol; 1998 Jul; 39(1):63-73. PubMed ID: 9674399
[TBL] [Abstract][Full Text] [Related]
5. Recalcitrant tinea corporis as the presenting manifestation of patch-stage mycosis fungoides.
Hubert JN; Callen JP
Cutis; 2003 Jan; 71(1):59-61. PubMed ID: 12553631
[TBL] [Abstract][Full Text] [Related]
6. The treatment of mycosis fungoides.
Mestel DS; Beyer M; Steinhoff M; Sterry W; Assaf C
G Ital Dermatol Venereol; 2008 Dec; 143(6):395-408. PubMed ID: 19169212
[TBL] [Abstract][Full Text] [Related]
7. Exfoliative erythroderma. Skin biopsy is required to determine the cause of this pruritic eruption.
Levine N
Geriatrics; 2000 Aug; 55(8):25. PubMed ID: 10953683
[No Abstract] [Full Text] [Related]
8. [Mycosis fungoides. Clinical characteristics and treatment of 6 patients].
Dotterud LK; Aarstein K; Falk ES
Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1850-2. PubMed ID: 1853318
[TBL] [Abstract][Full Text] [Related]
9. Phototherapy of mycosis fungoides.
Trautinger F
G Ital Dermatol Venereol; 2017 Dec; 152(6):597-606. PubMed ID: 28845954
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides: classic disease and variant presentations.
Howard MS; Smoller BR
Semin Cutan Med Surg; 2000 Jun; 19(2):91-9. PubMed ID: 10892710
[TBL] [Abstract][Full Text] [Related]
11. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
13. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of cutaneous T-cell lymphoma.
Abel EA
Dermatol Clin; 1985 Oct; 3(4):647-64. PubMed ID: 2878755
[TBL] [Abstract][Full Text] [Related]
15. Multiple melanocytic nevi restricted to mycosis fungoides patches in pediatric and young-adult patients. The potential role of local immunosuppression.
Martinez-Escala ME; Amin SM; Sable KA; Gerami P; Guitart J
Pediatr Dermatol; 2019 Mar; 36(2):232-235. PubMed ID: 30656726
[TBL] [Abstract][Full Text] [Related]
16. Photochemotherapy for mycosis fungoides.
Roenigk HH
Arch Dermatol; 1977 Aug; 113(8):1047-51. PubMed ID: 889332
[TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
Hoppe RT; Wood GS; Abel EA
Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
[TBL] [Abstract][Full Text] [Related]
18. Diffuse, progressive hyperpigmentation: an unusual skin manifestation of mycosis fungoides.
David M; Shanon A; Hazaz B; Sandbank M
J Am Acad Dermatol; 1987 Jan; 16(1 Pt 2):257-60. PubMed ID: 3819062
[TBL] [Abstract][Full Text] [Related]
19. Juvenile mycosis fungoides with large-cell transformation: Successful treatment with psoralen with ultraviolet A light, interferon-alfa, and localized radiation.
Chan WH; Lewis DJ; Hinojosa T; Curry JL; Duvic M
Pediatr Dermatol; 2018 Jan; 35(1):e13-e16. PubMed ID: 29159918
[TBL] [Abstract][Full Text] [Related]
20. Phototherapy of Mycosis Fungoides.
Hodak E; Pavlovsky L
Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
